Dr. Marc Claessens SRL
Dr. Marc Claessens reported total assets of €1.06m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Dr. Marc Claessens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets +39 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Marc Claessens's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 127,939 € | ||||
| Equity | 695,896 € | ||||
| Cash | 337,226 € | ||||
| EBITDA | 211,790 € | ||||
| Total assets | €1.06m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Dr. Marc Claessens's financial analysis
- Solvency65.9%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Marc Claessens
Dr. Marc Claessens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.634.142
- VAT number
- BE0832634142
- Peppol
- Registered · 0208:0832634142 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 2010
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Marc Claessens (SRL) has been based in Schilde since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 127,939 € and equity of 695,896 €; its revenue is not published. Its solvency stands at 65.9%, below the median of its sector (72.2%).
Companies similar to Dr. Marc Claessens
Companies in the same business, of comparable size and area, outside its group.
- Dr. Katie WOLLAERT Medical specialists activities Schilde · balance sheet €1.05m
- Dokter VAN DEN Eeden Elke Medical specialists activities Schilde · balance sheet €1.04m
- Aestiva Medical specialists activities Charleroi · balance sheet €1.05m
- R.M.G. Medical specialists activities Mouscron · balance sheet €1.04m
- Wilmet Medicale Medical specialists activities Ham-sur-Heure-Nalinnes · balance sheet €1.07m
- Dr. Anne Aerts Medical specialists activities Sint-Truiden · balance sheet €1.06m
- Dr. Yves VANDEKERCKHOVE Medical specialists activities Bruges · balance sheet €1.06m
- DERMATOLOGY and LASER PRACTICE Medical specialists activities Saint-Gilles · balance sheet €1.05m
Frequently asked questions about Dr. Marc Claessens
What is the revenue of Dr. Marc Claessens?
Dr. Marc Claessens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Marc Claessens?
In Belgium, the VAT number is the company number prefixed with BE: BE0832634142 for Dr. Marc Claessens, if the company is VAT-registered. Its company number (CBE) is 0832.634.142.
Where is the registered office of Dr. Marc Claessens?
According to the CBE register, the registered office of Dr. Marc Claessens is in 2970 Schilde.
What is the equity of Dr. Marc Claessens?
At the close of the 2025 financial year, the equity of Dr. Marc Claessens amounts to 695,896 €, a solvency of 65.9% of total assets.
Who manages Dr. Marc Claessens?
The register lists 1 active mandates at Dr. Marc Claessens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Marc Claessens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →